Conference Calendar - The 33rd International Papillomavirus Conference

Times are stated in CEST (GMT + 2 / UTC + 2)
Every effort has been made to convert the IPVC 2020 scientific program into a fully virtual program. Thank you to all the presenters who have submitted their recordings in advance. These are available as on-demand webcasts in the interactive program on the virtual conference platform. Please note that some presenters were not able to pre-record their presentations, therefore there are still some sessions with missing presentations.

To view the pre-conference workshops, you need to register for them separately. Please contact: reg_ipvc20@kenes.com
You will then receive an email with instructions on how to login to the workshops’ platform.

Displaying One Session

View

Basic Science Oral Session

00670 - Oral Session 4: Vaccines and New Treatment Approaches (ID 23)

Session Type

Basic Science Oral Session

Session Date

07/22/2020

Session Time

08:45 - 10:15

Room

Hall D

Chair(s)

Watch Stream
Session Webcast

Session Webcast

[{"name":"ATOMIC LAYER DEPOSITION TECHNOLOGY FOR PREPARING SINGLE-SHOT, THERMOSTABLE HUMAN PAPILLOMAVIRUS VACCINES. \u003Csmall\u003E(ID 427)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":427,"presentation":"ATOMIC LAYER DEPOSITION TECHNOLOGY FOR PREPARING SINGLE-SHOT, THERMOSTABLE HUMAN PAPILLOMAVIRUS VACCINES. \u003Csmall\u003E(ID 427)\u003C\/small\u003E","session":"Oral Session 4: Vaccines and New Treatment Approaches","presenter":"Robert L. Garcea (United States of America)","photo":""},"playlist":[{"name":"ATOMIC LAYER DEPOSITION TECHNOLOGY FOR PREPARING SINGLE-SHOT, THERMOSTABLE HUMAN PAPILLOMAVIRUS VACC","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/Robert L Garcea - IPVC20 - PRESENTATION id 427.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/23\/Robert L Garcea - IPVC20 - PRESENTATION id 427.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/3B534A55.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/Robert L Garcea - IPVC20 - PRESENTATION id 427.vtt"}]},{"name":"SENSITIVITY OF HUMAN PAPILLOMAVIRUS (HPV) LINEAGE AND SUBLINEAGE VARIANT PSEUDOVIRUSES TO NEUTRALIZATION BY NONAVALENT VACCINE ANTIBODIES \u003Csmall\u003E(ID 410)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":410,"presentation":"SENSITIVITY OF HUMAN PAPILLOMAVIRUS (HPV) LINEAGE AND SUBLINEAGE VARIANT PSEUDOVIRUSES TO NEUTRALIZATION BY NONAVALENT VACCINE ANTIBODIES \u003Csmall\u003E(ID 410)\u003C\/small\u003E","session":"Oral Session 4: Vaccines and New Treatment Approaches","presenter":"Simon Beddows (United Kingdom)","photo":""},"playlist":[{"name":"Simon Beddows - IPVC20 - 410 -Ready","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/Simon Beddows - IPVC20 - 410 -Ready-.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/23\/Simon Beddows - IPVC20 - 410 -Ready-.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/F87ACDB8.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/Simon Beddows - IPVC20 - 410 -Ready-.vtt"}]},{"name":"TOWARDS A CGMP-GRADE CHIMERIC PAPILLOMAVIRUS VACCINE: PROTECTION OVER ONE YEAR OF HPV16 RG-1 VLP COMPARED TO A GARDASIL-9 VACCINATION IN PRE-CLINICAL PAPILLOMAVIRUS ANIMAL MODELS \u003Csmall\u003E(ID 437)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":437,"presentation":"TOWARDS A CGMP-GRADE CHIMERIC PAPILLOMAVIRUS VACCINE: PROTECTION OVER ONE YEAR OF HPV16 RG-1 VLP COMPARED TO A GARDASIL-9 VACCINATION IN PRE-CLINICAL PAPILLOMAVIRUS ANIMAL MODELS \u003Csmall\u003E(ID 437)\u003C\/small\u003E","session":"Oral Session 4: Vaccines and New Treatment Approaches","presenter":"Joshua W. Wang (United States of America)","photo":""},"playlist":[{"name":"TOWARDS A CGMP-GRADE CHIMERIC PAPILLOMAVIRUS VACCINE: PROTECTION OVER ONE YEAR OF HPV16 RG-1 VLP COM","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/Joshua Wang - IPVC20 - presentation 437.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/23\/Joshua Wang - IPVC20 - presentation 437.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/3868022A.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/Joshua Wang - IPVC20 - presentation 437.vtt"}]},{"name":"TARGETING DNA DAMAGE RESPONSE AS A STRATEGY TO TREAT HPV INFECTIONS \u003Csmall\u003E(ID 945)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":945,"presentation":"TARGETING DNA DAMAGE RESPONSE AS A STRATEGY TO TREAT HPV INFECTIONS \u003Csmall\u003E(ID 945)\u003C\/small\u003E","session":"Oral Session 4: Vaccines and New Treatment Approaches","presenter":"Thomas R. Broker (United States Minor Outlying Islands)","photo":""},"playlist":[{"name":"TARGETING DNA DAMAGE RESPONSE AS A STRATEGY TO TREAT HPV INFECTIONS","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/IPVC 20 - P945 - S670 - N. Sanjib Banerjee .mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/23\/IPVC 20 - P945 - S670 - N. Sanjib Banerjee .mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/1D9FC5A1.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/IPVC 20 - P945 - S670 - N. Sanjib Banerjee .vtt"}]},{"name":"FIRST EXAMPLE OF CURING CANCER USING CRISPR\/CAS GENE EDITING. TREATING HPV CANCERS IN PRECLINICAL ANIMAL MODELS. \u003Csmall\u003E(ID 703)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":703,"presentation":"FIRST EXAMPLE OF CURING CANCER USING CRISPR\/CAS GENE EDITING. TREATING HPV CANCERS IN PRECLINICAL ANIMAL MODELS. \u003Csmall\u003E(ID 703)\u003C\/small\u003E","session":"Oral Session 4: Vaccines and New Treatment Approaches","presenter":"Nigel A. McMillan (Australia)","photo":""},"playlist":[{"name":"FIRST EXAMPLE OF CURING CANCER USING CRISPR\/CAS GENE EDITING. TREATING HPV CANCERS IN PRECLINICAL AN","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/GMT20200619-044818_Nigel-McMi_2560x1440.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/23\/GMT20200619-044818_Nigel-McMi_2560x1440.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/D9E62765.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/GMT20200619-044818_Nigel-McMi_2560x1440.vtt"}]},{"name":"LONG-TERM HPV-SPECIFIC IMMUNE RESPONSE AFTER ONE VERSUS TWO AND THREE DOSES OF BIVALENT HPV VACCINATION IN DUTCH GIRLS \u003Csmall\u003E(ID 204)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":204,"presentation":"LONG-TERM HPV-SPECIFIC IMMUNE RESPONSE AFTER ONE VERSUS TWO AND THREE DOSES OF BIVALENT HPV VACCINATION IN DUTCH GIRLS \u003Csmall\u003E(ID 204)\u003C\/small\u003E","session":"Oral Session 4: Vaccines and New Treatment Approaches","presenter":"Hella Pasmans (Netherlands)","photo":""},"playlist":[{"name":"LONG-TERM HPV-SPECIFIC IMMUNE RESPONSE AFTER ONE VERSUS TWO AND THREE DOSES OF BIVALENT HPV VACCINAT","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/Hella Pasmans - IPVC20- Presentation 204.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/23\/Hella Pasmans - IPVC20- Presentation 204.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/94417329.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/Hella Pasmans - IPVC20- Presentation 204.vtt"}]},{"name":"THERAPEUTICAL REMOVAL OF PRE-EXISTING PAPILLOMAVIRUS INFECTION IN RHESUS MACAQUES BY VACCINATION WITH ADENOVIRAL VECTOR \u003Csmall\u003E(ID 791)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":791,"presentation":"THERAPEUTICAL REMOVAL OF PRE-EXISTING PAPILLOMAVIRUS INFECTION IN RHESUS MACAQUES BY VACCINATION WITH ADENOVIRAL VECTOR \u003Csmall\u003E(ID 791)\u003C\/small\u003E","session":"Oral Session 4: Vaccines and New Treatment Approaches","presenter":"Ditte Boilesen (Denmark)","photo":""},"playlist":[{"name":"THERAPEUTICAL REMOVAL OF PRE-EXISTING PAPILLOMAVIRUS INFECTION IN RHESUS MACAQUES BY VACCINATION WIT","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/791 Ditte Boilesen.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/23\/791 Ditte Boilesen.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/BC52FE06.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/23\/791 Ditte Boilesen.vtt"}]}]

Oral Session 4: Vaccines and New Treatment Approaches Hall D

ATOMIC LAYER DEPOSITION TECHNOLOGY FOR PREPARING SINGLE-SHOT, THERMOSTABLE HUMAN PAPILLOMAVIRUS VACCINES. (ID 427)

Session Date

07/22/2020

Session Time

08:45 - 10:15

Room

Hall D

Session Type

Basic Science Oral Session

Session Name

Oral Session 4: Vaccines and New Treatment Approaches

Lecture Time

08:45 - 09:00

Presenter

Robert L. Garcea (United States of America)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 4: Vaccines and New Treatment Approaches Hall D

SENSITIVITY OF HUMAN PAPILLOMAVIRUS (HPV) LINEAGE AND SUBLINEAGE VARIANT PSEUDOVIRUSES TO NEUTRALIZATION BY NONAVALENT VACCINE ANTIBODIES (ID 410)

Session Date

07/22/2020

Session Time

08:45 - 10:15

Room

Hall D

Session Type

Basic Science Oral Session

Session Name

Oral Session 4: Vaccines and New Treatment Approaches

Lecture Time

09:00 - 09:12

Presenter

Simon Beddows (United Kingdom)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 4: Vaccines and New Treatment Approaches Hall D

TOWARDS A CGMP-GRADE CHIMERIC PAPILLOMAVIRUS VACCINE: PROTECTION OVER ONE YEAR OF HPV16 RG-1 VLP COMPARED TO A GARDASIL-9 VACCINATION IN PRE-CLINICAL PAPILLOMAVIRUS ANIMAL MODELS (ID 437)

Session Date

07/22/2020

Session Time

08:45 - 10:15

Room

Hall D

Session Type

Basic Science Oral Session

Session Name

Oral Session 4: Vaccines and New Treatment Approaches

Lecture Time

09:12 - 09:24

Presenter

Joshua W. Wang (United States of America)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 4: Vaccines and New Treatment Approaches Hall D

TARGETING DNA DAMAGE RESPONSE AS A STRATEGY TO TREAT HPV INFECTIONS (ID 945)

Session Date

07/22/2020

Session Time

08:45 - 10:15

Room

Hall D

Session Type

Basic Science Oral Session

Session Name

Oral Session 4: Vaccines and New Treatment Approaches

Lecture Time

09:24 - 09:36

Presenter

Thomas R. Broker (United States of America)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 4: Vaccines and New Treatment Approaches Hall D

FIRST EXAMPLE OF CURING CANCER USING CRISPR/CAS GENE EDITING. TREATING HPV CANCERS IN PRECLINICAL ANIMAL MODELS. (ID 703)

Session Date

07/22/2020

Session Time

08:45 - 10:15

Room

Hall D

Session Type

Basic Science Oral Session

Session Name

Oral Session 4: Vaccines and New Treatment Approaches

Lecture Time

09:36 - 09:48

Presenter

Nigel A. McMillan (Australia)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 4: Vaccines and New Treatment Approaches Hall D

LONG-TERM HPV-SPECIFIC IMMUNE RESPONSE AFTER ONE VERSUS TWO AND THREE DOSES OF BIVALENT HPV VACCINATION IN DUTCH GIRLS (ID 204)

Session Date

07/22/2020

Session Time

08:45 - 10:15

Room

Hall D

Session Type

Basic Science Oral Session

Session Name

Oral Session 4: Vaccines and New Treatment Approaches

Lecture Time

09:48 - 10:00

Presenter

Hella Pasmans (Netherlands)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 4: Vaccines and New Treatment Approaches Hall D

THERAPEUTICAL REMOVAL OF PRE-EXISTING PAPILLOMAVIRUS INFECTION IN RHESUS MACAQUES BY VACCINATION WITH ADENOVIRAL VECTOR (ID 791)

Session Date

07/22/2020

Session Time

08:45 - 10:15

Room

Hall D

Session Type

Basic Science Oral Session

Session Name

Oral Session 4: Vaccines and New Treatment Approaches

Lecture Time

10:00 - 10:12

Presenter

Ditte Boilesen (Denmark)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 4: Vaccines and New Treatment Approaches Hall D

Online Chat Q&A for this session is called: BASIC SCIENCE ORAL SESSION 4: VACCINES AND NEW TREATMENT APPROACHES. You can join the online chat Q&A and discussions for this session by going back to the Lobby and entering the Networking Lounge. Speakers are encouraged to be online in the chat room at the time this session is stated to end. All times are in CEST. (ID 1775)

Session Date

07/22/2020

Session Time

08:45 - 10:15

Room

Hall D

Session Type

Basic Science Oral Session

Session Name

Oral Session 4: Vaccines and New Treatment Approaches

Lecture Time

10:12 - 10:12